Monash University

Embargoed and Restricted Access

Reason: Under embargo until 30 August 2025. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library.

Sustainability in inhaled drug delivery for global health

posted on 2022-08-24, 23:24 authored by ANDREW JOHN LESLIE MCARTHUR
The overwhelming majority of maternal deaths occur in the world’s poorest countries. Severe haemorrhaging post-childbirth is the most common cause of maternal death but is preventable with an injection of oxytocin. However, barriers exist to the use of oxytocin in these low-resource health settings, and there is substantial unmet need for more accessible medicines that are cost-effective, high-quality and easy-to-use. An inhalable form of oxytocin presents an opportunity to reduce maternal mortality if it can be sustainably developed, manufactured and implemented. This thesis explores new methods to improve the sustainability of inhaled oxytocin by addressing affordability, useability and quality of inhaled drug delivery for global health applications.


Campus location


Principal supervisor

Michelle Mcintosh

Additional supervisor 1

Victoria Oliver

Year of Award


Department, School or Centre

Drug Delivery, Disposition and Dynamics

Additional Institution or Organisation

Monash Institute of Pharmacy and Pharmaceutical Sciences


Doctor of Philosophy

Degree Type



Faculty of Pharmacy and Pharmaceutical Sciences